Feed EPRT
EP

Essential Properties Realty Trust EPRT · NYSE

$25.79 +1.66% (+$0.42)

Summary

80 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 40 USD is left as net profit.
  • Revenue grew by 25% a year over the last 3 years.
  • The share price is below the Bulios Fair Price.
  • It has raised its dividend 7 years in a row.

What to watch

  • It missed profit estimates 6 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap

Price against the Bulios Fair Price

P/E against its own last 5 years

P/E against the industry (REIT - Diversified)

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 20.5 USD for 1 USD of yearly profit. Over the last five years it was 26.1 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 28% a year over 5 years. Over the last 3 years it grew by 25% a year. For the next fiscal year analysts expect revenue to grow by 11%. Earnings per share grew by 8.9% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (REIT - Diversified) 3.0 USD

Out of every 100 USD of revenue, 40 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.

Financial health in detail

Does it pay a dividend?

Moderate, at risk
Yield
4.97%
Paid out of profit
102%
Raised in a row
7 years

You receive $1.26 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $34.46 is 34% above today's price. 86% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.